PMID: 9540057Apr 16, 1998Paper

The effect of the anti-angiogenic agent TNP-470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice

Journal of Neuro-oncology
H J BernsenA J Van der Kogel

Abstract

The effect of the anti-angiogenic agent TNP-470 on tumor growth, vascular area, vascular density and tumor perfusion of two different subcutaneously implanted human glioma xenografts (E98 and E106) in nude mice was evaluated. Vascular parameters were investigated with an image analysis system. For both tumor lines a small but significant tumor growth suppression was observed. However, no differences in vascular parameters between TNP-470 treated tumors and controls could be found after 6 weeks of treatment. It is concluded that although TNP-470 is a promising anti-angiogenic agent in many tumor types, at least 2 glioma lines seem to be partly resistant to its anti-angiogenic effects. Further evaluation of the effects of combination of TNP-470 and cytostatic agents or radiotherapy in human glioma xenografts are required to determine the place of anti-angiogenic therapy in general and treatment with the anti-angiogenic agent TNP-470 more specifically in the treatment of human gliomas.

Citations

Dec 21, 2000·Current Oncology Reports·M E Linskey
Aug 5, 2005·Biology of Reproduction·Catrin S RutlandChristopher A Mitchell
Aug 31, 1999·The Annals of Pharmacotherapy·H B NewtonL K McCoy
Nov 4, 2000·Expert Opinion on Investigational Drugs·E A Kruger, W D Figg
Apr 20, 2006·International Journal of Clinical Oncology·Shigeru KandaHiroshi Kanetake
Dec 25, 2010·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Dongxiao YaoXianli Zhu
Nov 28, 2000·Expert Opinion on Investigational Drugs·H B Newton
Jan 12, 2008·Molecular Cancer Therapeutics·An ClaesWilliam P J Leenders
May 18, 2000·Cancer Treatment Reviews·M M EatockS B Kaye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.